MidWest Drug Development Conference
ONLINE EVENT | Oct. 4-5, 2021
2021-10-04 08:00:00
Register!
Downloads
  • 2021 Program
  • Flyer
  • 2021 Schedule
  • 2019 Program
  • 2018 Program
  • Map & Other Info (Coming soon!)
  • Home
  • Schedule
  • Venue
  • Technologies
    • Categories
    • Institutions
    • Startups
    • Previous Technologies
  • Sponsors
  • News
  • Contact
  • Home
  • Schedule
  • Venue
  • Technologies
    • Categories
    • Institutions
    • Startups
    • Previous Technologies
  • Sponsors
  • News
  • Contact

Previous Technologies

Below are lists of technologies presented at previous MidWest Drug Development conferences. Technologies are listed according to year and in alphabetic order. Subscribe to get important updates as they happen, or register to join us in 2021!

Subscribe!
2019 MWDD

2019 Technology Presentations

Antibacterials for methicillin, vancomycin resistant bacteria Mps1 kinase inhibitor as a treatment for solid tumors
Antibiotics to treat highly resistant enterococcusNanoparticle drug delivery systems
Antimicrobial peptides for therapeuticsNanoparticle-miRNA conjugate reduces inflammation, oxidative stress
Antisense oligonucleotides to treat spinal muscular atrophyNew PDE4B selective inhibitors improve inflammatory disease treatments
Bacterial glycosyltransferase inhibitors work as anti-virulence compoundsNovel crocetin compound prevents, treats pancreatic cancer
CAR-NK therapy for lupusNovel mithramycin derivatives for cancer chemotherapy
CAR T approach could prevent Type 1 diabetesNovel peptide antagonists for modulating GPCR pharmacology
Combine nanoparticles, checkpoint blockade therapy Peptide-based methods to treat neurological injury, disease
Composite biodegradable formulation promotes bone regeneration in diabeticsPreventative therapy treats post-traumatic osteoarthritis
DHODH inhibitors to treat hematological malignanciesProtease inhibitor drugs with improved PK, bioavailability
Dopaminergic ligands to treat tissue fibrosisSelective estrogen receptor modulator (ER-Beta agonist) as a new approach to targeting cancer
Extended Par-4 protein to treat cancerSHetA2 combination therapy for cancer
Family of small molecule drugs to treat diabetes complicationsSmall molecule inhibitors of EYA3 to treat cancer, hypertension diabetic retinopathy
Fast-acting, reversible neuromuscular blockers Small molecule inhibitors of NAMPT
Furoxans to treat neurodegenerative disordersSmall molecule ligand for PSMA-targeted radioligand therapy
GGDPS inhibitors for the treatment of cancerSmall molecule Rac inhibitor as new therapy
Glucocorticoid prodrugs for the treatment of nephritisSmall molecule treatment targets lymphoblastic leukemia/lymphoma
Harness tissue regeneration to treat ulcers, intractable wounds Synthetic mimics of malonyl-CoA as fatty acid synthase inhibitors
In situ activation of Car T cells for therapyTreat macular degeneration with cell therapy
Kappa opioid receptor antagonists to treat depression, anxiety Veratridine targets colon cancer cells
Low-molecular weight anti-PD-L1 peptide for cancer immunotherapyVSV cDNA libraries for cancer immuno/virotherapy
2018 MWDD

2018 Technology Presentations

Anti-cancer Drugs Based on Natural CompoundsNF-kB Inhibitors
Broad Spectrum AntiviralsNon-Invasive Leads for Eye Vascular Disease
Carrier-free Nanoparticle FormulationNon-opioid for Treating Chronic Pain
CCL21 Nanoparticles for Cancer ImmunotherapyNovel Anthelmintic Drugs
Chemical Agents for Antifungal ApplicationsPeptides for Treatment of Ischemia/Reperfusion
Compounds for the Prevention of Heart FailurePeptoid cancer drugs targeting PCNA
Copper-Activated Antibacterial DrugsPOSH Inhibitor-based Cancer Therapy
Delivery Platform for drugs and gene therapyProstate Cancer Vaccine
Drug Delivery System for Targeting Multiple MyelomaPVX Broad Spectrum Antiviral
Fatty Acid Uptake InhibitorsSaracatinib for epileptic seizures
Gastric pH Control for the Treatment of Acid RefluxSensory Neuron Actin Remodeling in Pain
Her2 Targeted Antibody Drug ConjugateSMN2 Catalytic Core for Spinal Muscle Atrophy
Histone Deacetylase InhibitorsSoluble Antigen Arrays for Autoimmune Diseases
Hsp90? Selective InhibitorsSuper-antibiotic
Immune Stimulating PeptidesTargeting Sigma-2 Receptor for Cancer
Influenza VaccineTheranostics for Personalized Medicine
Long Acting Antiretroviral FormulationsTherapy for the Reversal of Type 1 Diabetes
Mps1 Kinase InhibitorsTR3 Biologics for the Treatment of Cancer
Natural Surfactant Helps With ARDSWater Soluble Glucagon Derivative
Neuroprotection by Mitochondria-targeted Metformin

Logo

MIDWEST DRUG DEVELOPMENT CONFERENCE
Bringing together industry and the best university drug development researchers in the Midwest
An Online Event
Oct. 4-5, 2021

Latest News
  • Presentation schedule set for 2021 September 21, 2021
  • MWDD moves to a virtual event in 2021 August 17, 2021
  • Sponsorship, presentation slots nearly full July 29, 2021
  • Registrations are now open for 2021 March 25, 2021
Twitter Hightlights
  • Today's the day!
    491 days ago
  • Schedule is set for the 2021 MidWest Drug Development Conference. Register today! https://t.co/5SvzL4EhuV
    504 days ago
  • No surprise to see some incredible innovations out of @UWMadison that could change drug delivery approaches, cancer… https://t.co/h90yfHwC5k
    505 days ago

Follow us! @DrugMw